American Academy of Physical Medicine and Rehabilitation: “PASC Dashboard.”
Janna Friedly, MD, Director, Post-COVID Rehabilitation and Recovery Clinic, University of Washington.
National Institutes of Health: “Coronavirus Disease 2019 (COVID-19) Treatment Guidelines,” “REGID: Studying COVID,” “RECOVER Program Takes First Steps Towards Clinical Trials to Better Understand Long-Term COVID.
Cancer: “Prevalence and Symptoms of Moderate to Severe Fatigue: A Multicenter Study of Cancer Patients and Survivors.”
National Institute for Health Care and Excellence: “Chronic Fatigue Syndrome/Myositis (or Encephalopathy): Diagnosis and Management.”
Monica Verduzco-Gutierrez, MD, Chair of Rehabilitation Medicine, Director, COVID-19 Recovery Clinic, University of Texas Health Science Center at San Antonio.
PM&R: “Multidisciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Fatigue in Post-Acute Consequences of SARS-CoV-2 Infection (PASC) Patients.”
The Journal of Head Trauma Rehabilitation: “Efficacy of amantadine hydrochloride in reducing chronic traumatic brain injury irritability and aggression.”
Central nervous system drugs: “Modafinil: A review of its pharmacology and clinical efficacy in the treatment of narcolepsy.”
Frontiers in Neurology: “Methylphenidate treatment of cognitive impairment in adults after mild to moderate traumatic brain injury: Rationale, efficacy, and neurophysiology.”
PM&R: “Multidisciplinary Collaborative Guideline Statement on the Assessment and Treatment of Cognitive Symptoms in Patients with Acute Sequelae of SARS-CoV-2 Infection (PASC).”
Annals of Clinical and Translational Neurology: “Persistent Neurological Symptoms and Cognitive Dysfunction in Non-Hospitalized Covid-19 Long-haul Truckers.”
Alba Miranda Azola, MD, Co-Director, Post-Acute COVID-19 Team, Johns Hopkins University School of Medicine, Baltimore.
US National Library of Medicine: “SARS-CoV-2 Viral Resistance Study (PASC) – a long-term study of COVID-19.
PolyBio: “LongCovid Research Consortium.
Gary H. Gibbons, MD, Director, National Heart, Lung, and Blood Institute.